- ホーム
- > 洋書
- > 英文書
- > Science / Mathematics
Full Description
Biosimilars and Biologics in Cancer Therapy: An Era in Therapeutic Strategies addresses the challenges and opportunities in biosimilars and biologics, integrating the latest evidence, regulatory landscapes, economic implications, and strategies to enhance cancer management. The book aims to create an all-inclusive educational resource, bridge the gap between research and clinical practice, and inspire future research in oncology. The book provides a comprehensive examination of cancer therapeutics, starting with an introduction to biologics and biosimilars, their historical development, and foundational principles. It explains their mechanisms of action, drug development processes, regulatory landscapes, and clinical applications through case studies. Emerging therapeutic strategies, including combination therapies and personalized medicine, are also covered. This book benefits researchers, oncologists, pharmacologists, pathologists, and other healthcare professionals by offering up-to-date insights into the clinical aspects of biological medications and their biosimilars. Contributions from global experts ensure readers gain the latest advancements and practical guidance on integrating these therapies into clinical practice and research.
Contents
1. Introduction to Biosimilars and Biologics
2. Opportunities and Challenges in the Biosimilars and Biologics
3. Impact of Biosimilars and Biologics in Cancer Treatment
4. Clinical Applications of Biologics and Biosimilars in Oncology
5. Biosimilars and Biologics in Breast Cancer
6. Biosimilars and Biologics in Gastric and Colorectal Cancer
7. Biosimilars and Biologics in Cervical Cancer
8. Biosimilars and Biologics in Lung Cancer
9. Biosimilars and Biologics in Hepatocellular Carcinoma
10. Biosimilars and Biologics in Brain Tumor
11. Biosimilars and Biologics in Pancreatic Cancer
12. Biosimilars and Biologics in Prostate Cancer
13. Biosimilars and Biologics in Ovarian Cancer
14. Biosimilars and Biologics in Bone Cancer
15. Biosimilars and Biologics in Endometrial/Uterine Cancer
16. Biosimilars and Biologics in Urothelial Carcinoma
17. Biosimilars and Biologics in Melanoma
18. Biologics and Biosimilars from the Bench to the Bedside in Oncology
19. Recent Evidence of Biologics and Biosimilars and its Perspectives on Clinical Advances and Emerging Approaches
20. Marching of Biologics and Biosimilars in Artificial Intelligence and Machine Learning as Tools to Detect Various Cancer
